John Gallagher Power - 15 Jul 2026 Form 4 Insider Report for CONMED Corp (CNMD)

Reporting relationship: Executive Vice President & CFO
Issuer ticker: CNMD
Reported as of: 15 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jul 2026, 15:09:22 UTC
Prior SEC filing: 13 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Thomas Fistek for John Gallagher by Power of Attorney

Key filing fact

John Gallagher Power filed Form 4 for CONMED Corp (CNMD) on 17 Jul 2026.

Key facts

This page summarizes John Gallagher Power's Form 4 filing for CONMED Corp (CNMD).
3 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 17 Jul 2026, 15:09.

Change

Previous filing in this sequence was filed on 13 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001628991 Primary reporting owner

Gallagher John E

Relationship: Executive Vice President & CFO
Address: C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO
Signature: /s/ Thomas Fistek for John Gallagher by Power of Attorney
Signature date: 17 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNMD transaction Derivative

RSUs (Restricted Stock Units)

Award

Transaction value
Shares: +35,054
Change %
Price: $0.000000^*
Shares after: 35,054
Date: 15 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,054
Exercise price: $0.000000
Footnotes: F1

CNMD transaction Derivative

RSUs (Restricted Stock Units)

Award

Transaction value
Shares: +26,875
Change %: +77%
Price: $0.000000^*
Shares after: 61,929
Date: 15 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 26,875
Exercise price: $0.000000
Footnotes: F1

CNMD transaction Derivative

Options To Purchase Common Stock

Award

Transaction value
Shares: +30,536
Change %
Price: $0.000000^*
Shares after: 30,536
Date: 15 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,536
Exercise price: $42.79
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

Footnote F2

The stock options were granted under CONMED Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.